Question:
Light directed synthesis on silica wafers is a part of
Light directed synthesis on silica wafers is a part of
Updated On: Jul 11, 2024
- Bulk synthesis
- Combinatorial synthesis
- Assymetric synthesis
- Inorganic synthesis
Hide Solution
Verified By Collegedunia
The Correct Option is B
Solution and Explanation
The correct option is (B): Combinatorial synthesis
Was this answer helpful?
0
0
Top Questions on Neurohumoral transmission in autonomic and central nervous system
- Which of the following is not a GABA derivative:
- GPAT - 2024
- Pharmacology
- Neurohumoral transmission in autonomic and central nervous system
- Which of the following is not a GABA derivative:
- GPAT - 2024
- Pharmacology
- Neurohumoral transmission in autonomic and central nervous system
- Fight or flight responses are mediated by
- GPAT - 2023
- Pharmacology
- Neurohumoral transmission in autonomic and central nervous system
- A drug ‘X’ is more selective for the 1 subunit of BZD receptors. It lacks effect on slow-wave sleep, minimum residual daytime sedation, no rebound insomnia on discontinuation, low abuse potential. Which of the following can be ‘X’?
- GPAT - 2023
- Pharmacology
- Neurohumoral transmission in autonomic and central nervous system
- Match List I with List II
List I-Drugs List II-Classes A Anakinra I IL‐2 receptor antagonist B Basiliximab II TNFα inhibitors C Infliximab III Calcineurin inhibitors D Tacrolimus IV mTOR inhibitors E - V IL‐1 receptor antagonist Choose the correct answer from the options given below:
- GPAT - 2022
- Pharmacology
- Neurohumoral transmission in autonomic and central nervous system
View More Questions
Questions Asked in GPAT exam
- Match the following:
(P) Schedule H
(Q) Schedule G
(R) Schedule P
(S) Schedule F2
Descriptions:
(I) Life period of drugs
(II) Drugs used under RMP
(III) List of Prescription Drugs
(IV) Standards for surgical dressing- GPAT - 2025
- Drug therapy
- Minimum manufacturing space for 'Habb-Unani medicine' as per Schedule of D and C Act?
- GPAT - 2025
- Pharma Techniques
- If the label or the container bears the name of an individual or company purporting to be the manufacturer of the drug, which individual or company is fictitious or does not exist, it is:
- GPAT - 2025
- Drug therapy
- Match the following:
(1) Schedule FF
(2) Schedule F3
(3) Schedule V
(4) Schedule Y
Descriptions:
(P) Standards of patent and proprietary medicines
(Q) Requirements and guidelines for clinical trials
(R) Standards for sterilized umbilical tapes
(S) Standards for Ophthalmic preparations- GPAT - 2025
- Drug therapy
Match the following Class and their Drug:
(1) Alkylating (P) 5-fluorouracil
(2) Platinum analog (Q) Cisplatin
(3) Antimetabolite (R) Cetuximab
(4) EGF receptor inhibitor (S) Chlorambucil- GPAT - 2025
- Biostatistics and Research Methodology
View More Questions